{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:46:46Z","timestamp":1793713606042,"version":"4.6.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00415-011-6344-y","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T05:47:18Z","timestamp":1323755238000},"page":"1312-1316","source":"Crossref","is-referenced-by-count":61,"title":["Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis"],"prefix":"10.1007","volume":"259","author":[{"given":"Fredrik","family":"Romi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T.","family":"Plant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Erik","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"6344_CR1","first-page":"933","volume":"51","author":"JM Lindstr\u00f8m","year":"1998","unstructured":"Lindstr\u00f8m JM, Seybold ME, Lennon VA, Whittingham S, Duane DD (1998) Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975 classical article. Neurology 51:933\u2013939","journal-title":"Neurology"},{"key":"6344_CR2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0960-8966(00)00173-5","volume":"11","author":"A Evoli","year":"2001","unstructured":"Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P (2001) Therapeutic options in ocular myasthenia gravis. Neuromuscul Disord 11:208\u2013216","journal-title":"Neuromuscul Disord"},{"key":"6344_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/WCO.0b013e3282f4098e","volume":"21","author":"U Luchanok","year":"2008","unstructured":"Luchanok U, Kaminski HJ (2008) Ocular myasthenia: diagnostic and treatment recommendations and the evidence base. Curr Opin Neurol 21:8\u201315","journal-title":"Curr Opin Neurol"},{"key":"6344_CR4","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/0952-7915(93)90105-2","volume":"5","author":"N Wilcox","year":"1993","unstructured":"Wilcox N (1993) Myasthenia gravis. Curr Opin Immunol 5:910\u2013917","journal-title":"Curr Opin Immunol"},{"key":"6344_CR5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0165-5728(95)00169-7","volume":"64","author":"Z Li","year":"1996","unstructured":"Li Z, Forester N, Vincent A (1996) Modulation of acetylcholine receptor function in TE671 (rhabdomyocyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis. J Neuroimmunol 64:179\u2013183","journal-title":"J Neuroimmunol"},{"key":"6344_CR6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"6344_CR7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","volume":"55","author":"J McConville","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A (2004) Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55:580\u2013584","journal-title":"Ann Neurol"},{"key":"6344_CR8","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.1093\/emboj\/16.16.4951","volume":"16","author":"C Fuhrer","year":"1997","unstructured":"Fuhrer C, Sugiyama JE, Taylor RG, Hall ZW (1997) Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscle. EMBO J 16:4951\u20134960","journal-title":"EMBO J"},{"key":"6344_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.153.1.1","volume":"153","author":"LS Borges","year":"2001","unstructured":"Borges LS, Ferns M (2001) Agrin-induced phosphorylation of the acetylcholine receptor regulates cytoskeletal anchoring and clustering. J Cell Biol 153:1\u201312","journal-title":"J Cell Biol"},{"key":"6344_CR10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2007.10.018","volume":"195","author":"F Romi","year":"2008","unstructured":"Romi F, Gilhus NE, Luckman S (2008) Serum matrix metalloproteinase-3 (MMP-3) levels are elevated in myasthenia gravis. J Neuroimmunol 195:96\u201399","journal-title":"J Neuroimmunol"},{"key":"6344_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000322737","volume":"65","author":"G Helgeland","year":"2011","unstructured":"Helgeland G, Petzold A, Luckman SP, Gilhus NE, Plant GT, Romi F (2011) Matrix metalloproteinases in myasthenia gravis. Eur Neurol 65:53\u201358","journal-title":"Eur Neurol"},{"key":"6344_CR12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","volume":"62","author":"F Romi","year":"2005","unstructured":"Romi F, Skeie GO, Gilhus NE, Aarli JA (2005) Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol 62:442\u2013446","journal-title":"Arch Neurol"},{"key":"6344_CR13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2010.04.024","volume":"225","author":"G Helgeland","year":"2010","unstructured":"Helgeland G, Petzold A, Hoff JM, Gilhus NE, Plant GT, Romi FR (2010) Anti-heat shock protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barr\u00e9 syndrome. J Neuroimmunol 225:180\u2013183","journal-title":"J Neuroimmunol"},{"issue":"9","key":"6344_CR14","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133(9):2734\u20132748","journal-title":"Brain"},{"issue":"8","key":"6344_CR15","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9(8):776\u2013785","journal-title":"Lancet Neurol"},{"issue":"20","key":"6344_CR16","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","volume":"70","author":"KM Tan","year":"2008","unstructured":"Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ (2008) Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 70(20):1883\u20131890","journal-title":"Neurology"},{"key":"6344_CR17","first-page":"740583","volume":"2011","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Utsugisawa K, Nagane Y, Suzuki N (2011) Three types of striational antibodies in myasthenia gravis. Autoimmune Dis 2011:740583","journal-title":"Autoimmune Dis"},{"key":"6344_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nature00978","volume":"419","author":"G Yellen","year":"2002","unstructured":"Yellen G (2002) The voltage-gated potassium channels and their relatives. Nature 419:35\u201342","journal-title":"Nature"},{"issue":"1\u20132","key":"6344_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2005.08.017","volume":"170","author":"S Suzuki","year":"2005","unstructured":"Suzuki S, Satoh T, Yasuoka H, Hamaguchi Y, Tanaka K, Kawakami Y, Suzuki N, Kuwana M (2005) Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol 170(1\u20132):141\u2013149","journal-title":"J Neuroimmunol"},{"issue":"5","key":"6344_CR20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","volume":"8","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN, Sanders DB (2009) Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8(5):475\u2013490","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"6344_CR21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","volume":"230","author":"S Suzuki","year":"2011","unstructured":"Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Kuwana M, Suzuki N (2011) Clinical and immunological differences between early and late-onset myasthenia gravis in Japan. J Neuroimmunol 230(1\u20132):148\u2013152","journal-title":"J Neuroimmunol"},{"key":"6344_CR22","first-page":"H1599","volume":"276","author":"AD Wickenden","year":"1999","unstructured":"Wickenden AD, Jegla TJ, Kaprielian R, Backx PH (1999) Regional contributions of KV1.4, KV4.2, and KV4.3 to transient outward K+ current in rat ventricle. Am J Physiol 276:H1599\u2013H1607","journal-title":"Am J Physiol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6344-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6344-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6344-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:22:58Z","timestamp":1559056978000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6344-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["6344"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6344-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}